Heike Prinz
Member of the Board of Management — Talent; Labor DirectorBayer
PharmaceuticalsView Profile →Chief People & Organization Officer · Novartis
Rob Kowalski is Novartis’s chief people and organization officer. His earlier pharmaceutical career centered on regulatory affairs and drug development, including global regulatory leadership at Novartis.
Last reviewed: Nov 15, 2026
Rob Kowalski is Novartis’s chief people and organization officer. His earlier pharmaceutical career centered on regulatory affairs and drug development, including global regulatory leadership at Novartis.
Kowalski studied pharmaceutical sciences and earned a Doctor of Pharmacy at the University of Wisconsin–Madison. His earlier industry career included regulatory leadership at Schering-Plough and Pharmacia, companies later incorporated into Merck and Pfizer respectively.
At Novartis he became senior vice president and head of Regulatory Affairs in 2009, first in the United States and then, from 2015 to 2017, in Switzerland. He also held US development leadership and country medical-development responsibilities.
In 2018 he became executive vice president and global head of Regulatory Affairs. That year he also served temporarily as head of Global Drug Development and chief medical officer. He later served briefly as interim president of Novartis Corporation in the United States in 2021.
Kowalski became chief people and organization officer in 2021. The move placed a leader with extensive drug-development and regulatory experience in charge of the company’s people strategy, organizational capabilities and operating-model changes.
Doctor of Pharmacy — University of Wisconsin–Madison.
Bachelor’s degree — University of Wisconsin–Madison — Pharmaceutical Sciences.